This is a complete list of the most recent 200 press releases issued by major news sources for companies trading on the OTCBB exchange. Check out the updating news as it happens.

To get a more detailed quote on a company, go to our stock quote page.

Another week has come to a close.  Some of the top headlines from OTC-listed companies for this week included:

Imagenetix, Inc. (OTCBB:IAGX) received an adverse decision in an interim arbitration in its disbute with TriPharma, LLC and its principal, Evan Dameshek to the tune of $2.2 million plus other Read More

While many companies have fought to find business recently, Premier Alliance Group, Inc. (OTCBB:PIMO) has had a successful month of August.  Today, the professional services company announced another new client win with the engagement of Entropic Communications (NASDAQ:ENTR) to perform a Gap Analysis of their current systems and recommend a three-year Information Technology Strategy.

Entropic is a leading fabless semiconductor company that is engineering the future of connected home networking and entertainment by providing next-generation silicon and software technologies to the world’s leading cable, telco and satellite service providers, OEMs and consumer electronics manufacturers. As a co-founder of MoCA (Multimedia over Coax Alliance), Entropic pioneered and continues to evolve the way high-definition television-quality video and other multimedia and digital content such as movies, music, games and photos are brought into and delivered throughout the home. For more information, visit Entropic at www.entropic.com.

• August 4^th - Curaspan Health Group of Boston, MA
• August 8^th - REVA Medical and Regulus Therapeutics, Inc.
• August 15^th - Associated Engineering

Commenting on the news today, President of Premier Mark Elliott stated,

“We have worked with Entropic Communications on GRC-based initiatives in the past and are pleased to use our expertise as it relates to technology to service them. Our capability to deliver successfully on key efforts has helped us gain the trust of our clients and has allowed us to utilize our growing base of expertise to help in other strategic ways.”

Premier Alliance Group (PIMO) Stock Quote and News:

Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.

mPhase Technologies, Inc. (OTCBB:XDSL) just released news disclosing that it has signed a Letter of Intent to purchase Fairfield, New Jersey-based Energy Innovative Products, Inc. Energy Innovative Products is focused on developing proprietary technologies to reducing energy usage in refrigeration and cooling systems amongst other things. Energy’s technologies are used to create solutions that control voltage and current used by a wide array of compressor systems. Read the full press release, previous XDSL news and get a XDSL stock quote.

Cellceutix Corporation (OTCQB:CTIX) issued big news this morning that they have received the “thumbs-up” from one of the world’s leading cancer research centers to host the Company’s clinical trials for Kevetrin™.  Cellceutix is developing (and posting strong pre-clinical results) Kevetrin™ as an indication for a multitude of cancers including drug-resistant, pancreatic, lung, leukemia and breast cancers.  The cancer center was not disclosed, but there are several industry-leading centers in the east/northeast United States.  U.S. News recently released their list of the top cancer hospitals in the U.S.  The Top 5 included Memorial Sloan-Kettering in New York, NY; Johns Hopkins in Baltimore, MD; and Dana-Farber/Brigham and Women’s in Boston, which will have investors wondering which center will be hosting the trials Read More